CBD Health Foods Ltd, trading as British Cannabis, has entered into an exclusive trademark and know-how license agreement with Elixinol Wellness Limited, the wholly owned subsidiary of Elixinol Wellness Pty Ltd, to sell CBD products across the UK.
Given the complex and ongoing developments with the regulatory environment in the UK, Elixinol made the decision in 2021 to cease trading in the UK and EU markets and instead move to an indirect route-to-market model by seeking a licensing partner in the UK.
The Elixinol and British Cannabis agreement enables Elixinol’s brand to continue to be distributed in the UK, while handing over the UK operations and associated cost.
The appointment of British Cannabis as the sole and exclusive licensee of Elixinol-branded products in the UK, for a three-year term, marks a pivotal agreement in the course of the UK cannabinoid market. Both parties are committed to invest in a renewed support of the existing Elixinol sales channels, key retail customers and consumers. The shared aim is to improve revenues across the board, while building on the legacy set by Elixinol’s founders over 10 years ago, ensuring a continued execution of Elixinol’s global strategy.
Established in 2015, British Cannabis is the largest independently owned, producer, manufacturer and distributor of legal cannabis-derived products in the UK. It has a suite of successful branded flagship products, along with a range of white label brands Powered by British Cannabis. With a focus on innovation, quality, accuracy and compliance, this focus now looks set to support the dynamic range of wellness solutions at Elixinol.
“We are delighted about our partnership with British Cannabis who are the most established manufacturer and distributor of branded and white label CBD products in the UK,” said Elixinol Global CEO Oliver Horn. “British Cannabis’ Canabidol brand is widely distributed in UK pharmacies, demonstrating the company’s credentials and capabilities to build brands in sophisticated retail channels. British Cannabis’ manufacturing capability also allows us to manufacture Elixinol products in the UK and thus create a more efficient supply chain solution. Through the partnership with British Cannabis, UK consumers will now continue to be able to buy their favourite Elixinol products and we are very excited to see the brand continue following many years of building the brand.”